Rasmussen, J H <br/><br/>
Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  04 2019 
 - 629-636 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Validation Study 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdz010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Biomarkers, Tumor--analysis<br/>Chemoradiotherapy--methods<br/>Cisplatin--therapeutic use<br/>Clinical Decision-Making<br/>Cyclin-Dependent Kinase Inhibitor p16--analysis<br/>DNA, Viral--isolation & purification<br/>Datasets as Topic<br/>Denmark--epidemiology<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Models, Biological<br/>Neoplasm Recurrence, Local--epidemiology<br/>Oropharyngeal Neoplasms--genetics<br/>Papillomaviridae--genetics<br/>Papillomavirus Infections--genetics<br/>Predictive Value of Tests<br/>Prognosis<br/>Risk Assessment--methods<br/>Squamous Cell Carcinoma of Head and Neck--genetics